Allogene Therapeutics Inc. (ALLO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Allogene Therapeutics Inc...

    NASDAQ: ALLO · Real-Time Price · USD
    1.15
    0.04 (3.60%)
    At close: Sep 05, 2025, 3:59 PM
    1.16
    0.85%
    After-hours: Sep 05, 2025, 07:04 PM EDT

    Allogene Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 75.22M 83.16M 61.9M 173.31M
    Short-Term Investments
    		 217.26M 365.54M 455.42M 283.99M
    Long-Term Investments
    		 80.67M 3.65M 59.15M 370.18M
    Other Long-Term Assets
    		 33.39M 16.9M 32.67M 28.3M
    Receivables
    		 1.9M 1.7M 3.3M 6M
    Inventory
    		 n/a n/a -62.45M -20.02M
    Other Current Assets
    		 9.01M n/a 62.45M 14.02M
    Total Current Assets
    		 303.39M 459.12M 528.82M 471.32M
    Property-Plant & Equipment
    		 131.26M 163.18M 196.43M 181.02M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 245.32M 183.72M 288.25M 579.5M
    Total Assets
    		 548.71M 642.84M 817.08M 1.05B
    Account Payables
    		 5.39M 5.9M 13.89M 10.26M
    Deferred Revenue
    		 n/a 86K 885K 156K
    Short-Term Debt
    		 n/a n/a n/a 3.2M
    Other Current Liabilities
    		 12.15M 11.66M 15.02M 1.45M
    Total Current Liabilities
    		 35.52M 37.08M 53.73M 47.91M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 7.76M 5.18M 5.85M 7.79M
    Total Long-Term Liabilities
    		 91.01M 93.53M 100.97M 77.72M
    Total Liabilities
    		 126.53M 130.6M 154.7M 122.23M
    Total Debt
    		 90.76M 95.12M 101.12M 73.13M
    Common Stock
    		 212K 169K 144K 142K
    Retained Earnings
    		 -1.82B -1.56B -1.24B -903.35M
    Comprehensive Income
    		 -89K -955K -9.93M -2.57M
    Shareholders Equity
    		 422.18M 512.23M 665.87M 916.41M
    Total Investments
    		 297.93M 369.19M 514.57M 654.17M

    Add to Watchlist